Outcome Prediction to Erlotinib in Gastroesophageal Adenocarcinomas: Can We Improve Epidermal Growth Factor Receptor and Phospho-AKT Testing?
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details